Our thought leaders and specialist consultants have a wealth of case studies, news, and blog articles to check out.
Introduction Similar to broad AI trends, clinical trial AI landscape is active, progressive, and everchanging. While...
From significant fundraisings and strategic partnerships to regulatory achievements and clinical advancements, 2024 marked an exciting period of forwa
The traditional "one-size-fits-all" concept is shifting towards a more customized approach in personalized or precision medicine (PM),
The MEDiSTRAVA Patient Engagement team were recently awarded the PIF TICK – the only independently assessed quality...
Introduction Let’s face it: “Omnichannel”, as a term, is overused. We’re all tired of it. Especially in...
Soft tissue sarcomas (STS) are heterogeneous malignancies with diverse clinical presentations and outcomes. This study...
Anthony Haywood, Vice President of Clinical Trials Optimization at MEDiSTRAVA, examines the evolving landscape of clinical trial recruitment and reten
Randomized controlled trials often have restrictive inclusion criteria, resulting in trial participants who do not represent the real-world population
Physicians and healthcare professionals (HCPs) struggle with the vast amounts of new information provided to them, related to patient care. As...
The inclusion of patients in medical publications is no longer a novel concept. However, ensuring the patient voice is included through co-authorship
Introduction As the cornerstone of advancing medical science, clinical trials require broad diversity among...
